Elizabeth Aby is a Gastroenterology physician affiliated with University of Minnesota. OpenAlex indexes 144 publications with 1,651 citations (h-index 20); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
406 Harvard St SE # Mmc36
Minneapolis, MN 554550362
Telephone
612-625-8999Provider last certified this registry record 19 Sept 2024.
Clinical trials
- Evaluation of an Oral Microbiota-based Therapeutic as a Treatment Option for PSC
Sponsor: University of Minnesota
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- INTERCEPT PHARMACEUTICALS, INC.Program year20231 payment
- Cook Medical LLCProgram year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
44.8%Osmotic Laxative22.4%Lactulose59%Constulose27%Gavilyte-G14%Part D<11 patientsRifamycin Antibacterial9.9%Xifaxan100%Part D≥14 patients+ 3 more classes in this area
Cardiovascular
29.2%Aldosterone antagonist (MRA)13.1%Spironolactone100%Part D≥31 patientsLoop diuretic9.6%Furosemide100%Part D≥24 patients+ 1 more class in this area
Cancer & immunology
16.2%Calcineurin inhibitor16.2%Tacrolimus88%Cyclosporine Modified12%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Financial toxicity in living donor liver transplantation: A call to action for financial neutrality
American Journal of Transplantation
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Vicki Morrison, MD
University of Minnesota
Maria Hordinsky, MD
University of Minnesota
Paul Tuite, MD
University of Minnesota
Allyson Hart, MD
University of Minnesota
Charles Rice, MD
The Rockefeller University
Edward Loftus, MD
Mayo Clinic Rochester
Naga Chalasani, MD
Indiana University School of Medicine
Bruce Sands, MD
Icahn School of Medicine at Mount Sinai
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”